Add-On Payment Accelerates Commercialization Of NeuroPace’s RNS
This article was originally published in The Gray Sheet
Executive Summary
The company is focused on expanding the number of centers that use its responsive neurostimulator RNS system to treat seizures in patients with epilepsy, while eyeing other indications. It’s also partnering with the Defense Department on a memory restoration project.